Haleon’s latest half-year results were highly encouraging, but not necessarily for the reasons that investors assume. Certainly, the consumer healthcare company and owner of popular brands such as Aquafresh, Centrum and Panadol delivered a solid financial performance during the period. For example, its organic revenue growth (which excludes the imp…
Questor: Further FTSE 100 outperformance lies ahead for this maker of household names
Date:


